Move your health innovation closer to patients
The Academy of Translational Medicine (ATM) helps UBC researchers navigate the payer, evidence, regulatory and strategic decisions involved in moving promising health innovations forward.
ATM supports therapeutics, medical devices, diagnostics and health software.
🔒 All information submitted through the intake process will be kept strictly confidential.
Is the ATM Platform right for your project?
You are eligible to apply if you are a UBC student, postdoctoral fellow, faculty member or staff member developing an eligible health innovation.
Who can apply?
- UBC faculty
- Postdoctoral fellows
- Students
- Staff
What can be submitted?
- Therapeutics
- Medical devices
- Diagnostics
- Health software
How ATM can help
Moving a health innovation from discovery toward real-world use requires more than strong science. ATM brings together expertise across four areas that can help identify what your project needs next.
Payer strategy
Health technology assessment readiness, reimbursement and pricing pathway mapping, health economics including cost-effectiveness analysis and budget impact, and market access pathway mapping across the payer landscape.
Evidence strategy
Evidence design guidance for regulatory submission, covering clinical trial design, safety and efficacy, and for health technology assessment, covering clinical benefit, patient value, cost-effectiveness and implementation.
Regulatory strategy
Regulatory affairs consultations, regulatory document templates and project-specific guidance, access to the ATM regulatory large language model and regulatory expert network, and Regulatory Advisory Council review.
Strategic asset valuation
Asset prioritization framework and guidance, competitive landscape analysis, real-options analysis, and preclinical early health technology assessment including investment and economic modelling.
You do not need to determine which type of support you need before applying. The intake process helps ATM understand your project, its current stage and where support may be most useful.
What happens after you apply?
1. Submit
Tell us about your innovation, its current stage and the evidence available so far.
2. Review
The ATM Intake Group reviews your submission using the ATM Evaluation Framework.
3. Evaluate
The Intake Group evaluates your project’s needs, translational readiness and alignment with ATM focus areas to determine the extent of support.
4. Connect
Every project is connected with the relevant ATM expertise, starting with a three-hour consultation.
How proposals are evaluated
Every submission is reviewed. The ATM Intake Group evaluates submissions across five evidence categories to determine the extent and type of support your project receives:
- Equity and access: priority populations and accessibility
- Unmet medical need: disease burden, severity, urgency and gaps in existing care
- Healthcare cost: costs associated with the condition and existing competing products
- Product innovation: competing products, potential benefit, marketability and uncertainty in the evidence base
- Technology readiness: technology readiness level and biomanufacturing feasibility, where applicable
Please provide as much relevant information as you currently have. Complete submissions help the Intake Group evaluate your project’s needs and readiness, and match you with the right expertise.
Learn more about the ATM Intake Group.
Ready to submit your project?
Complete the ATM Platform Intake Form and Evidence Summary Tool to have your project evaluated for Platform support.
🔒 Your submission will be kept strictly confidential.